NCT01728194View on ClinicalTrials.gov

Emotional and Cognitive Control in Late-Onset Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Depression
Interventions
DRUG

Escitalopram

20 mg target dose for 12 weeks

OTHER

Magnetic Resonance Imaging

Structural and functional MRI of the brain for research purposes.

Trial Locations (2)

10065

Weill Cornell Medical College, New York

10605

Weill Cornell Medical College - Westchester Division, White Plains

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT01728194 - Emotional and Cognitive Control in Late-Onset Depression | Biotech Hunter | Biotech Hunter